FindTrial
Sign In

Changes and prognostic value of right ventricular function in heart failure with improved ejection fraction

Changes and prognostic value of right ventricular function in heart failure with improved ejection fraction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082263
Enrollment
Unknown
Registered
2024-03-25
Start date
2024-03-25
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure with improved ejection fraction (HFimpEF) is defined as previous LVEF 40%

Interventions

Observation group:None

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.HFimpEF patients in the cohort from Nov 2010 to Jun 2024; 2.age >=18 years old; 3.gender unlimited; 4.with written informed consent;

Exclusion criteria

Exclusion criteria: 1.severe primary valvular heart disease; 2.chronic kidney disease stage 4-5; 3.autoimmune disease related heart failure; 4.malignant tumors; 5.life expectancy less than a year;

Design outcomes

Secondary

MeasureTime frame
reduced LVEF <40%;—

Primary

MeasureTime frame
cardiovascular death or heart failure readmission;—

Countries

China

Contacts

Public ContactLin Liu

Peking University First Hospital

lindaliu01@sina.com+86 10 83575218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026